![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 22, 2010 2:45:16 PM
"Rumors of a lucrative buy-out or partnership have been swirling around the company during the past two weeks. Multiple sources told BioMedReports, that details about "a big announcement involving Positron and a much larger, publicly traded NYSE company worth at least $25 billion" could come as early as next Monday.
We reached out to Positron's Chariman of the Board, Patrick G. Rooney and the head of the small molecular imaging company focused on Nuclear Cardiology has confirmed that his company "is currently in discussions with a potential partner in our industry."
Rooney refused to offer any assurances or details about when an agreement might be reached. "
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM